Jennifer Eads MD
Endocrine Cancer, Gastrointestinal Cancer, Hematologic Oncology
Assistant Professor, Medicine, Case Western Reserve University School of Medicine
Join to View Full Profile
3400 Civic Center BlvdFl 3Philadelphia, PA 19104
Phone+1 215-615-5858
Fax+1 215-615-3349
Dr. Eads is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 2005 - 2009
Tufts University School of MedicineClass of 2005
Certifications & Licensure
PA State Medical License 2018 - 2026
OH State Medical License 2005 - 2019
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Methoxyamine and Temozolomide in Treating Patients With Advanced Solid Tumors Start of enrollment: 2007 Aug 16
- Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction Start of enrollment: 2013 Aug 23
- Yttrium-90 Radioembolization + Nivolumab for Liver + Extra-hepatic Metastases From Colorectal Cancer Start of enrollment: 2018 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group.Lakshmi Rajdev, Gentry G King, Christopher H Lieu, Stacey A Cohen, Shubham Pant
JCO Precision Oncology. 2025-03-01 - 4 citationsPrediction ofLu-DOTATATE Therapy Outcomes in Neuroendocrine Tumor Patients Using Semi-Automatic Tumor Delineation onGa-DOTATATE PET/CT.Hwan Lee, Sarit T Kipnis, Remy Niman, Sophia R O'Brien, Jennifer R Eads
Cancers. 2023-12-31 - 1 citationsResponse to Letter to Editor re: "Combined Quantification of 18F-FDG and 68Ga-DOTATATE PET/CT for Prognosis in High-Grade Gastroenteropancreatic Neuroendocrine Neoplas...Hwan Lee, Ryusuke Nakamoto, Stephen E Moore, Austin R Pantel, Jennifer R Eads
Academic Radiology. 2022-09-01
Press Mentions
Leap Therapeutics Presents Positive DKN-01 Clinical Data in Biliary Tract Cancers at American Society of Clinical Oncology (ASCO) 2017 Annual MeetingMay 17th, 2017
Neuroendocrine Tumor Treatment Options Are GrowingMarch 25th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
